Brett Schrand
About Brett Schrand
Brett Schrand is a Senior Scientist with extensive experience in murine tumor models and pre-clinical drug development. He has a strong academic background and has contributed to multiple patents and scientific publications in the fields of cancer biology and immunology.
Work at Wave
Brett Schrand has been employed as a Senior Scientist at Wave Life Sciences since 2021. His role involves contributing to the development of innovative therapies in the field of molecular biology. He has leveraged his extensive experience in murine tumor models and drug development to advance the company's research initiatives. Schrand's position at Wave Life Sciences is part of his ongoing commitment to scientific advancement in cancer biology and immunology.
Education and Expertise
Brett Schrand holds a Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology, as well as Immunology, from the University of Miami Leonard M. Miller School of Medicine, where he studied from 2009 to 2014. He also earned a Bachelor of Arts and Sciences degree from Xavier University between 2005 and 2008. His educational background provides a solid foundation for his expertise in cancer biology, immunology, and pre-clinical drug development.
Background
Brett Schrand has a diverse professional background in academic and research settings. He served as a Postdoctoral Research Associate at the University of Miami, Miller School of Medicine from 2014 to 2016. He has held various positions, including Research Assistant Professor at both the University of Miami and the University of Pittsburgh, and Research Assistant at Cincinnati Children's Hospital Medical Center. His career has included significant roles at TCR² Therapeutics Inc. and Wave Life Sciences.
Achievements
Brett Schrand holds six patents, reflecting his focus on innovation and intellectual property in molecular biology. He has also contributed to ten scientific publications, which highlight his expertise in cancer biology and immunology. His work in designing proof of concept approaches has been essential for advancing early-stage discovery projects, showcasing his contributions to the scientific community.